Chapters

Transcript

Video

Harnessing the Immune System to Fight Cancer

With the entry of immune checkpoint inhibitors such as anti-PD1 and anti-CTLA-4 into the clinic, excitement about immune-based therapies for cancer has been growing. Three immunologists at the Medical University of South Carolina (MUSC)—Zihai Li, M.D., Ph.D., Shikhar Mehrotra, Ph.D., and Chrystal Paulos, Ph.D.—discuss the promise of immune-based therapies such as immune checkpoint blockade and adoptive cell transfer and how the researchers and clinicians at MUSC are helping advance the field.

More at Progressnotes, MUSC’s Medical Magazine

 

Related Presenters

Zihai Li, M.D., Ph.D..

Zihai Li, M.D., Ph.D.

Chairman and Professor Department of Microbiology & Immunology Program Leader Cancer Immunology Program Hollings Cancer Center Medical University of South Carolina (MUSC) Education Dr. Li received his medical degree from Henan Medical ...

View full profile

Chrystal Paulos, Ph.D..

Chrystal Paulos, Ph.D.

Associate Professor Microbiology and Immunology Surgery 2004-2007  Postdoctoral Fellow,  Surgery Branch, NCI, NIH 2007-2011  Postdoctoral Fellow, University of Pennsylvania Education 2004  Ph.D. Purdue University

View full profile

Shikhar Mehrotra, Ph.D..

Shikhar Mehrotra, Ph.D.

Associate Director, Cell Therapy Unit, Cell Evaluation & Therapy Shared Resource, Hollings Cancer Center, Medical University of South Carolina Dr. Mehrotra’s research interest centers on how to orchestrate a robust and long-lived ...

View full profile

ADVERTISEMENT

Related Videos